This issue may be avoided by targeting molecules that constitute tumor microenvironment, which would allow CRISPR/Cas system to access the paracrine or autocrine effects of subpopulation responsible for the whole tumor progression, just as the altered EDA+FN and VEGF in this study. This evidence concerns the gene FN1 and neoplasm.